https://biotechmorning.com/news/fda-bone-growth-stimulator-reclassification Biotech Morning en 2026-04-17T14:13:55.272Z The FDA Just Made It Way Easier to Sell a Bone-Healing Device https://biotechmorning.com/news/aligos-amoytop-china-hbv-deal Biotech Morning en 2026-04-17T14:13:13.091Z Aligos Just Sold Half the Map for $445 Million https://biotechmorning.com/news/terremoto-akt-inhibitor-358m-bet Biotech Morning en 2026-04-17T14:12:28.595Z The $358M Bet on a Cancer Target That Keeps Breaking Hearts https://biotechmorning.com/news/kailera-therapeutics-biggest-biotech-ipo-obesity Biotech Morning en 2026-04-17T14:11:46.388Z A Record Biotech IPO Just Bet $625M on Your Waistline https://biotechmorning.com/news/pancreatic-cancer-finally-blinked Biotech Morning en 2026-04-17T14:11:01.079Z The Cancer That Finally Blinked https://biotechmorning.com/news/alzheimers-anti-amyloid-drugs-trivial-benefits-report Biotech Morning en 2026-04-17T14:10:21.686Z The $6 Billion Question: Do Alzheimer's Blockbuster Drugs Actually Work? https://biotechmorning.com/news/beeline-medicines-300m-launch-bms-autoimmune Biotech Morning en 2026-04-17T14:09:36.186Z Bristol Myers Squibb Just Gave Away Five Drugs. One Startup Got Them All. https://biotechmorning.com/news/meiragtx-reacquires-eye-gene-therapy-jj Biotech Morning en 2026-04-17T14:08:48.314Z J&J Spent $415 Million on This Eye Gene Therapy. MeiraGTx Just Bought It Back for $25 Million. https://biotechmorning.com/news/storm-therapeutics-series-c-epitranscriptomics-sarcoma Biotech Morning en 2026-04-17T14:08:03.448Z The Biotech Field That Didn't Exist a Decade Ago Just Got Its Biggest Bet Yet https://biotechmorning.com/news/first-fsgs-drug-filspari-approved Biotech Morning en 2026-04-17T14:07:18.545Z The First-Ever Drug for a Kidney Disease That Destroys 50% of Patients https://biotechmorning.com/news/beeline-medicines-bain-bms-launch Biotech Morning en 2026-04-16T14:12:40.847Z The $300M Startup Built From Big Pharma's Leftovers https://biotechmorning.com/news/novartis-ceo-narasimhan-joins-anthropic-board Biotech Morning en 2026-04-16T14:11:52.227Z Why Novartis's CEO Just Took a Seat at AI's Most Interesting Table https://biotechmorning.com/news/lilly-foundayo-obesity-pill-fda-liver-safety Biotech Morning en 2026-04-16T14:11:00.407Z Lilly's New Obesity Pill Just Got Approved. The FDA Wants Receipts on Its Liver. https://biotechmorning.com/news/pill-rewriting-pancreatic-cancer-death-sentence Biotech Morning en 2026-04-16T14:10:17.453Z The Pill That's Rewriting Pancreatic Cancer's Death Sentence https://biotechmorning.com/news/spain-200m-biotech-fund-boston Biotech Morning en 2026-04-16T14:09:31.751Z Spain Just Planted a $200M Flag in Boston's Biotech Backyard https://biotechmorning.com/news/biotech-early-stage-funding-slump-2026 Biotech Morning en 2026-04-16T14:08:47.673Z Biotech's Baby Companies Are Starving https://biotechmorning.com/news/fda-rejects-six-peptides-compounding Biotech Morning en 2026-04-16T14:08:03.455Z The FDA Just Told Six Popular Peptides to Get Lost https://biotechmorning.com/news/novo-nordisk-openai-partnership Biotech Morning en 2026-04-16T14:07:20.020Z Novo Nordisk Just Handed OpenAI the Keys to Its Drug Lab https://biotechmorning.com/news/ocugen-gene-therapy-commercial-scalability Biotech Morning en 2026-04-16T14:06:33.776Z The Gene Therapy Company Betting Against Million-Dollar Price Tags